Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

we have demonstrated an increase in transgene expression of more than 600-fold from a minimal simian virus 40 (SV40) promoter and an increase in expression of 200-fold from the ITR in a vector ...

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

Here we show that an orally administered adeno-associated viral vector leads to persistent expression of a ß-galactosidase transgene in both gut epithelial and lamina propria cells, and that this ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

That therapy uses an adeno-associated virus (AAV) as a vector rather than a lentivirus, a vector type that features in approved gene therapies such as Roche's Luxturna and Novartis' Zolgensma.

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...